Ridgeback Bio
's headquarters is located in Miami, Florida. Ridgeback Bio generates $133.3K in revenue per employee Ridgeback Bio's top competitor is Entero Therapeutics, led by Richard Paolone, who is their Interim-CEO. Ridgeback Bio has 3 followers on Owler.Ridgeback Bio
's headquarters is located in Miami, Florida. Ridgeback Bio generates $133.3K in revenue per employee Ridgeback Bio's top competitor is Entero Therapeutics, led by Richard Paolone, who is their Interim-CEO. Ridgeback Bio has 3 followers on Owler.
News
Dec 11, 2024
PMLiVE
Ridgeback Bio: Merck and Ridgeback initiate phase 3 study of COVID-19 oral antiviral in high-risk adults
Jun 28, 2023
Yahoo
Ridgeback Bio: Merck-Ridgeback withdraw EU COVID drug application
Jun 28, 2023
Benzinga
Ridgeback Bio: Merck, Ridgeback Withdraw COVID-19 Pill European Application Amid Regulatory Hurdles
Feb 25, 2023
Indian Pharma Post
Ridgeback Bio: EMA recommends refusal of the marketing authorization for Lagevrio
Feb 24, 2023
Post Online Media
Ridgeback Bio: Merck/Ridgeback COVID-19 pill rejected in Europe
Feb 24, 2023
MarketWatch
Ridgeback Bio: : Merck and Ridgeback Biotherapeutics to appeal advisory panel to EU regulator's decision to recommend refusing authorization of their COVID antiviral
Feb 24, 2023
BioSpace
Ridgeback Bio: Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO (Molnupiravir)
Oct 08, 2022
Pharmabiz
Ridgeback Bio: Merck, Ridgeback provide update on new clinical and nonclinical studies of Lagevrio
Oct 07, 2022
Seeking Alpha
Ridgeback Bio: Merck, Ridgeback COVID pill Lagevrio fails to show benefit in older adults in UK study, mixed show in Israel data
Jul 08, 2022
Benzinga
Ridgeback Bio: Merck Partner Joins Forces With Emergent Bio To Increase Access To Ebola Treatment
Ridgeback Bio Competitors
1
2
3
4
5
6
7
8
9
10